News | 25 July 2026
Organon shareholders approve Sun Pharma acquisition proposal
Transaction moves closer to completion, pending regulatory approvals and other customary closing conditions
Transaction moves closer to completion, pending regulatory approvals and other customary closing conditions
Life sciences giant posts USD 11.99 billion in quarterly revenue, beats analyst estimates and lifts full-year revenue and profit guidance
CDMO business drives record growth
Acquisition of manufacturing facilities in Uttarakhand and Uttar Pradesh strengthens Akums' CDMO capabilities in skincare, wellness, hair care and marks its entry into colour cosmetics.
The company’s One India business recorded its highest-ever quarterly sales, growing 12% year-on-year, while the overall chronic portfolio mix improved to 60.4% in the market
Aims to accelerate drug development and clinical manufacturing support
The company posted sales of CHF 3.4 billion in H1 2026, representing 16.0% growth at constant exchange rates (CER) and 11.2% growth at actual exchange rates
Earnings rebound 97% sequentially despite North America pressure
_Limited.jpg)
The company posted a record consolidated Profit After Tax (PAT) of Rs. 206 crore in Q1 FY27
The company reported revenue from operations of Rs. 14,768 million in Q1FY27
Growth was led by oncology and specialty medicines, with sales increases across several flagship products
The EyeGility system is designed to provide smooth, controlled lens delivery through a 2.4mm incision
The deal adds SPR’s FDA-cleared SPRINT PNS System to Medtronic’s neuroscience portfolio
Acquisition aims to take HST Medical's heritage wellness brands to international markets while strengthening product innovation
Revenue climbs 13.7% YoY to Rs. 1,129 million
New clinical-stage company to advance PRMT5 and SOS1 cancer programmes through global clinical development
Subscribe To Our Newsletter & Stay Updated
